Edges in Network
| Network | GSE7696_top8000 - GSE7696 - SiGN-BN NNSR |
| Network Description | Glioblastoma from a homogenous cohort of patients treated within clinical trial |
| Node | SLC2A10 |
| Upstream (Parents) |
|---|
| (<<) MSN → SLC2A10 |
| (<<) ACSS3 → SLC2A10 |
| (<<) WWTR1 → SLC2A10 |
| (<<) EFEMP2 → SLC2A10 |
| (<<) ZNF217 → SLC2A10 |
| Downstream (Children) |
|---|
| SLC2A10 → SUSD4 (>>) |
| SLC2A10 → MSN (>>) |
| SLC2A10 → CMYA5 (>>) |
| SLC2A10 → CD9 (>>) |
| SLC2A10 → LITAF (>>) |
| SLC2A10 → CCDC46 (>>) |
| SLC2A10 → ACSS3 (>>) |
| SLC2A10 → CSRP2 (>>) |
| SLC2A10 → RAB34 (>>) |
| SLC2A10 → PCSK5 (>>) |
| SLC2A10 → TANK (>>) |
| SLC2A10 → EGF (>>) |
| SLC2A10 → PPIC (>>) |
| SLC2A10 → EVC (>>) |
| SLC2A10 → C1orf85 (>>) |
| SLC2A10 → EYA2 (>>) |
| SLC2A10 → FBXL13 (>>) |
| SLC2A10 → ZNF217 (>>) |
| SLC2A10 → B3GNT5 (>>) |
| SLC2A10 → PARVA (>>) |
| SLC2A10 → GALNT10 (>>) |
| SLC2A10 → PMP22 (>>) |
| SLC2A10 → NPEPL1 (>>) |
